Preview Mode Links will not work in preview mode

This Week in Cardiology

Jan 14, 2022

Xeno-transplantation, weight loss drugs, DOAC coverage, vitamin D, LAAC and frailty, and recalled LVADs are the topics John Mandrola, MD, discusses in this week’s podcast. To read a partial transcript or to comment, visit:

I – Xenotransplantation

- Pig Heart Successfully Transplanted to Man

- What Does a Pig-to-Human Heart Transplant Mean for Medicine?

II – Weight Loss Drugs

- Wegovy Tops Sibling Saxenda for Weight Loss

- Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight in Adults With Overweight or Obesity Without Diabetes

III – DOAC Coverage

- CVS Caremark Formulary Change Freezes Out Apixaban

IV – Vitamin D

- More Vitamin D Not Better for Reducing Cancer or CVD Incidence

- The D-Health Trial: a randomised controlled trial of the effect of vitamin D on mortality

- Vitamin D supplementation and prevention of cardiovascular disease and cancer in the Finnish Vitamin D Trial—a randomized controlled trial

- Association between vitamin D supplementation and mortality: systematic review and meta-analysis

V – LAAC and Frailty

- Frailty in patients undergoing percutaneous left atrial appendage closure

- Net Clinical Benefit of Left Atrial Appendage Closure Versus Warfarin in Patients With Atrial Fibrillation: A Pooled Analysis of the Randomized PROTECT-AF and PREVAIL Studies

VI – LVAD recall

- A High-Risk Medical Device Didn't Meet Federal Standards. The Government Paid Millions for More.

You may also like:

Medscape editor-in-chief Eric Topol, MD, and master storyteller and clinician Abraham Verghese, MD, on Medicine and the Machine

The Bob Harrington Show with Stanford University Chair of Medicine, Robert A. Harrington, MD.

Questions or feedback, please contact

This podcast is intended for US health professionals only.